Topical Pain Relief Industry - Regional Synopsis
North America Market Insights
The North America topical pain relief market is estimated to account for a share of approximately 40.8% by the end of 2037. The dominance of the region is attributable to the rising burden of chronic pain conditions among the aging population and rising sports injuries in the country. For instance, CMS reported that in 2024, the healthcare expenditure reached a value of USD 1.3 billion. Besides, as per the CDC reports, more than 25 million people in the region are affected by chronic pain. Furthermore, the U.S. FDA fast-tracked over 15 patches or gels in 2023, which significantly contributes to the market expansion.
Canada’s topical pain relief market is gaining traction due to the substantial investments from the federal and provincial sectors for pain management strategies. The market in Canada is projected to grow at 6.7% CAGR, further accelerating market expansion. For instance, in 2024, Ontario assigned USD 120.6 million for topical analgesics, aiming to provide treatment to over 500,000 arthritis patients in the country. Besides, the government support with regulatory approvals and healthcare initiatives improves access in remote and rural areas, further driving growth in the topical pain relief sector.
APAC Market Insights
The topical pain relief market in Asia Pacific is unfolding remarkable growth opportunities with expanding access to over-the-counter pain medications. The market in the region is projected to grow at 7.8% CAGR, fueled by the developmental tendency of countries such as Japan, China, and India. There is a fast-rising prevalence of musculoskeletal conditions in the region, which increases the medical awareness necessitating treatment access. Due to their affordability and ease of use, topical pain relief therapeutics are adopted by innumerable people. Furthermore, the governments in the region are highly supportive, allowing the domestic players to enhance their product portfolio and launch more of such effective formulations.
There is a great opportunity for the topical pain relief market in India, fueled by the rising burden of arthritis in the region and rural medical access. The market in India is projected to grow at 9.7% CAGR, reaching 2.5 billion during the forecast timeline. In 2024, nearly 2.9 million people in India were diagnosed with arthritis. For instance, in 2024, the government of India assigned 19% of its funding towards pain management under the Ayushman Bharat scheme, which covers nearly 500 million people for OTC analgesics. Thus, these factors significantly contribute to the market expansion and showcase lucrative growth opportunities.
